Kitano Masayuki, Ohnishi Hiroe, Makino Akiko, Miyamoto Tatsuo, Hayashi Yasuyuki, Mizuno Keisuke, Kaba Shinji, Kawai Yoshitaka, Kojima Tsuyoshi, Kishimoto Yo, Yamamoto Norio, Tomonaga Keizo, Omori Koichi
Department of Otolaryngology-Head and Neck Surgery, Graduate School of medicine, Kyoto University, Kyoto City, Japan.
Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto City, Japan.
Tissue Eng Part A. 2025 May;31(9-10):361-372. doi: 10.1089/ten.TEA.2024.0016. Epub 2024 Jun 27.
Investigating the infection mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the airway epithelium and developing effective defense strategies against infection are important. To achieve this, establishing appropriate infection models is crucial. Therefore, various models, such as cell lines and primary cultures, and models involving animals that exhibit SARS-CoV-2 infection and genetically humanized animals have been used as animal models. However, no animal model has been established that allows infection experiments with human cells under the physiological environment of airway epithelia. Therefore, we aimed to establish a novel animal model that enables infection experiments using human cells. Human induced pluripotent stem cell-derived airway epithelial cell-transplanted nude rats (hiPSC-AEC rats) were used, and infection studies were performed by spraying lentiviral pseudoviruses containing SARS-CoV-2 spike protein and the gene on the tracheae. After infection, immunohistochemical analyses revealed the existence of GFP-positive-infected transplanted cells in the epithelial and submucosal layers. In this study, a SARS-CoV-2 infection animal model including human cells was established mimicking infection through respiration, and we demonstrated that the hiPSC-AEC rat could be used as an animal model for basic research and the development of therapeutic methods for human-specific respiratory infectious diseases.
研究严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在气道上皮中的感染机制并制定有效的抗感染策略至关重要。要实现这一目标,建立合适的感染模型至关重要。因此,各种模型,如细胞系和原代培养物,以及涉及表现出SARS-CoV-2感染的动物和基因人源化动物的模型已被用作动物模型。然而,尚未建立能在气道上皮生理环境下用人细胞进行感染实验的动物模型。因此,我们旨在建立一种能用人细胞进行感染实验的新型动物模型。使用人诱导多能干细胞衍生的气道上皮细胞移植裸鼠(hiPSC-AEC大鼠),并通过将含有SARS-CoV-2刺突蛋白和该基因的慢病毒假病毒喷洒在气管上来进行感染研究。感染后,免疫组织化学分析显示在上皮层和黏膜下层存在绿色荧光蛋白(GFP)阳性感染的移植细胞。在本研究中,建立了一种模拟经呼吸道感染的包含人细胞的SARS-CoV-2感染动物模型,并且我们证明hiPSC-AEC大鼠可作为基础研究和开发针对人类特异性呼吸道传染病治疗方法的动物模型。